Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effect of a new marker, ADAM12, on Down risk figures in first trimester screening.
J Matern Fetal Neonatal Med. 2009 Jul;22(7):602-7. doi: 10.1080/14767050902755478.
J Matern Fetal Neonatal Med. 2009.
PMID: 19736612
Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland.
Valinen Y, Rapakko K, Kokkonen H, Laitinen P, Tekay A, Ahola T, Ryynanen M.
Valinen Y, et al.
Am J Obstet Gynecol. 2007 Mar;196(3):278.e1-5. doi: 10.1016/j.ajog.2006.11.040.
Am J Obstet Gynecol. 2007.
PMID: 17346554
Item in Clipboard
Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
Valinen Y, Peuhkurinen S, Järvelä IY, Laitinen P, Ryynanen M.
Valinen Y, et al.
Gynecol Obstet Invest. 2010;70(1):60-3. doi: 10.1159/000289178. Epub 2010 Feb 27.
Gynecol Obstet Invest. 2010.
PMID: 20197665
Item in Clipboard
Adding ADAM12 in risk calculation program does not improve the detection rate of trisomies 18 and 13 in first trimester screening.
Valinen Y, Marttala J, Sahravand M, Jarvela I, Honkasalo T, Laitinen P, Ryynanen M.
Valinen Y, et al.
J Matern Fetal Neonatal Med. 2012 Jun;25(6):822-5. doi: 10.3109/14767058.2011.590559. Epub 2012 Feb 6.
J Matern Fetal Neonatal Med. 2012.
PMID: 22309076
Item in Clipboard
Cite
Cite